| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| QURE | uniQure N.V. | Meek David D. | Director | Jun 16, 2023 | Sale | $18.85 | 2,290 | 43,167 | 22,481 | Jun 20, 2023, 05:25 PM | |
| QURE | uniQure N.V. | Meek David D. | Director | Feb 27, 2023 | Sale | $19.71 | 389 | 7,667 | 16,071 | Mar 01, 2023, 04:09 PM | |
| MRTX | Mirati Therapeutics, Inc. | Meek David D. | Chief Executive Officer | Jan 17, 2023 | Sale | $42.38 | 3,179 | 134,715 | 61,792 | Jan 19, 2023, 09:45 AM | |
| MRTX | Mirati Therapeutics, Inc. | Meek David D. | Chief Executive Officer | Dec 21, 2022 | Sale | $40.41 | 4,616 | 186,552 | 64,971 | Dec 21, 2022, 09:20 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Meek David D. | Director | Jul 07, 2022 | Option Exercise | $2.20 | 22,000 | 48,400 | 0 | Jul 11, 2022, 04:07 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Meek David D. | Director | Jul 11, 2022 | Option Exercise | $2.20 | 27,500 | 60,500 | 0 | Jul 11, 2022, 04:07 PM | |
| QURE | uniQure N.V. | Meek David D. | Director | Feb 28, 2022 | Sale | $16.70 | 602 | 10,053 | 7,380 | Mar 02, 2022, 05:34 PM | |
| QURE | uniQure N.V. | Meek David D. | Director | Mar 02, 2021 | Sale | $37.50 | 505 | 18,938 | 6,448 | Mar 04, 2021, 01:58 PM | |
| QURE | uniQure N.V. | Meek David D. | Director | Jan 28, 2020 | Sale | $62.19 | 722 | 44,903 | 3,226 | Jan 30, 2020, 08:54 PM | |
| BXLT | Baxalta Inc | Meek David D. | EVP and President, Oncology | Mar 03, 2016 | Option Exercise | $39.30 | 928 | 36,470 | 51,586 | Mar 07, 2016, 06:17 PM | |
| BXLT | Baxalta Inc | Meek David D. | EVP and President, Oncology | Sep 02, 2015 | Option Exercise | $35.03 | 791 | 27,709 | 24,277 | Sep 04, 2015, 04:11 PM | |
| ECYT | ENDOCYTE INC | Meek David D. | Chief Commercial Officer | Sep 12, 2013 | Option Exercise | $12.11 | 20,000 | 242,300 | 10,000 | Sep 16, 2013, 07:55 PM |
Menu